Executive Director, Corporate Strategy & Intelligence

Recursion•New York, NY

8d•$287,980 - $346,060•Hybrid

About The Position

Recursion is at a strategic inflection point. With a growing clinical pipeline, expanding global partnerships, and one of the most powerful AI-native end-to-end drug discovery platforms, we are seeking a strategist who can translate intelligence into decisive action. At Recursion, our mission is to industrialize and transform the development of medicines by integrating data-driven insights and advanced analytics throughout the entire development lifecycle. As an Executive Director in Corporate Strategy & Intelligence, you will play a pivotal role in defining Recursion’s competitive and commercial position and turn that understanding into a strategy that shapes pipeline prioritization, partnership decisions, and long-range growth. You will leverage competitive & commercial insights to be a principal architect of Recursion’s strategic choices, sharpening our BD focus and maximizing the potential for both scientific and commercial impact. Ideal candidates are equally comfortable building rigorous commercial models as they are presenting bold strategic recommendations to leadership, all with the goal of driving enterprise decision-making as we advance transformative medicines for patients.

Requirements

Advanced degree in a scientific, quantitative, business, or related field required; MBA, PhD, MD, or equivalent strongly preferred
10+ years of experience in competitive intelligence, pipeline differentiation strategy, forecasting and demand estimation, quantitative and qualitative market research, corporate strategy & business development in the pharma, biotech and/or life sciences consulting sector
Deep command of the drug development landscape, including therapeutic area dynamics, clinical-stage competitive assessments, regulatory strategy, and market access considerations
Proven track record building and delivering commercial assessments and strategic analyses that have directly influenced high-stakes decisions: pipeline prioritization, partnership strategy, go/no-go investments
Experience with AI-enabled drug discovery or platform biotechs is an advantage; as is an ability to translate complex platform capabilities into compelling commercial and competitive narratives
Experience partnering on or advising business development transactions (licensing, co-development, M&A) in a competitive intelligence or strategic context
Strong financial and analytical acumen: able to build, own, and critically challenge commercial models, scenario analyses, and valuation frameworks
Exceptional communication and executive presence—able to synthesize complexity into clear, actionable recommendations and present with confidence and conviction to internal and external stakeholders

Responsibilities

Lead commercial assessment, strategic fit analyses, and the design of competitive moats for pipeline assets from early validation through late-stage development. Integrate epidemiology, patient segmentation, competitive positioning, pricing & market access dynamics, and revenue forecasts to inform go/no-go, prioritization, and partnering decisions.
Own the end-to-end competitive intelligence function for specific Recursion initiatives and BD opportunities: leverage agentic approaches, as well as advanced analytics & modeling to define the strategic framework, build the intelligence infrastructure, and deliver timely, decision-grade insights on competitors, therapeutic area dynamics, evolving platform technologies, and the broader drug discovery ecosystem.
Grow and refine a real-time intelligence system that synthesizes complex signals from clinical data, regulatory filings, investor disclosures, scientific publications, partner pipelines, and industry events into a coherent, real-time-updated strategic picture. Strive to preempt market disruptions and identify white space opportunities.
Collaborate with functional line leaders and the C-suite to inform corporate strategy development and long-range planning, translating competitive and commercial intelligence into actionable strategic choices and high impact narratives on portfolio prioritization, platform positioning, partnership strategy, and growth vectors.
Propagate the Recursion mindset of radically changing lives by constantly seeking transformative improvements in how we advance innovative concepts for clinical benefit, all while ensuring Recursion’s strategy is grounded in competitive reality and built to move with urgency.